MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 20, 2005; DOI: 10.1124/mol.104.010850


0026-895X/05/6804-1142-1147$20.00
Mol Pharmacol 68:1142-1147, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.010850v1
68/4/1142    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamura, H.
Right arrow Articles by Shimada, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamura, H.
Right arrow Articles by Shimada, S.

Icilin Activates the {delta}-Subunit of the Human Epithelial Na+ Channel

Hisao Yamamura, Shinya Ugawa, Takashi Ueda, Masataka Nagao, and Shoichi Shimada

Departments of Molecular Morphology (H.Y., S.U., T.U., S.S.) and Forensic Medical Science (M.N.), Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan

The amiloride-sensitive epithelial Na+ channel (ENaC) regulates Na+ homeostasis in cells and across epithelia. Four homologous ENaC subunits ({alpha}, {beta}, {gamma}, and {delta}) have been isolated in mammals. The chemical activators acting on ENaC, however, are largely unknown. More recently, we have found that capsazepine activates human ENaC{delta} (hENaC{delta}), which is mainly expressed in the brain. In addition, here we show that icilin, which is a tetrahydropyrimidine-2-one derivative unrelated structurally to capsazepine, markedly enhanced the activity of hENaC{delta}{beta}{gamma} heteromultimer expressed in Xenopus laevis oocytes. The inward currents at a holding potential of -60 mV in hENaC{delta}{beta}{gamma}-expressing oocytes were increased by the application of icilin in a concentration-dependent manner with an EC50 value of 33 µM. The icilin-elicited current was mostly abolished by the addition of 100 µM amiloride or by the removal of external Na+. Homomeric hENaC{delta} was also significantly activated by icilin, whereas hENaC{alpha} activity was not affected by icilin, and icilin caused a slight inhibition of the hENaC{alpha}{beta}{gamma} current. Furthermore, icilin acted together with protons or capsazepine on hENaC{delta}{beta}{gamma}. These findings identify icilin as a novel chemical activator of ENaC{delta}, providing us with a lead compound for drug development in the degenerin/ENaC superfamily.


Received December 26, 2004; accepted July 20, 2005

Address correspondence to: Dr. Hisao Yamamura, Department of Molecular Morphology, Graduate School of Medical Sciences, Nagoya City University, 1 Kawasumi Mizuhocho Mizuhoku, Nagoya 467-8601, Japan. E-mail: yamamura{at}med.nagoya-cu.ac.jp




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Lu, F. Echeverri, D. Kalabat, B. Laita, D. S. Dahan, R. D. Smith, H. Xu, L. Staszewski, J. Yamamoto, J. Ling, et al.
Small Molecule Activator of the Human Epithelial Sodium Channel
J. Biol. Chem., May 2, 2008; 283(18): 11981 - 11994.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Yamamura, S. Ugawa, T. Ueda, and S. Shimada
Evans Blue Is a Specific Antagonist of the Human Epithelial Na+ Channel {delta}-Subunit
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 965 - 969.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics